# Tofacitinib

NDC: 27241-270
Generic name: Tofacitinib
Labeler / Manufacturer: Ajanta Pharma USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20260603

FDA application: ANDA219542

## Active ingredients

- TOFACITINIB CITRATE: 11 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"27241-270"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=27241-270
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=024bb9f2-8c26-4d9d-a33b-eb3c0a7c59ed